Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
Clinical trial NCT00841828 · COMPLETED
Trial details
- NCT number
- NCT00841828
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-12-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.